Suchergebnisse - "Tabarsi, Payam"

PubPharm (9)

1

Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran : randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial

enthalten in: BMJ (Clinical research ed.) | 2023

von Mohraz, M. | Vahdat, K. | Ghamari, S. | +15

ErratumIn: BMJ. 2023 Sep 25;382:2193. - PMID 37748804

2

Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine : a phase 3 randomized placebo-controlled trial

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Tabarsi, P. | Anjidani, N. | Shahpari, R. | +9

3

Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination : A randomized placebo-controlled trial

enthalten in: Immunology | 2022

von Tabarsi, P. | Anjidani, N. | Shahpari, R. | +5

4

Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine : a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Tabarsi, P. | Anjidani, N. | Shahpari, R. | +9

5

Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran : findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults

enthalten in: BMJ open | 2022

von Mohraz, M. | Salehi, M. | Tabarsi, P. | +13

ErratumIn: BMJ Open. 2022 Nov 7;12(11):e056872corr1. - PMID 36344009

6

No clinical benefit of high dose corticosteroid administration in patients with COVID-19 : A preliminary report of a randomized clinical trial

enthalten in: European journal of pharmacology | 2021

von Jamaati, H. | Hashemian, S. | Farzanegan, B. | +15

7

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases : A randomized controlled trial

enthalten in: International immunopharmacology | 2021

von Tabarsi, P. | Barati, S. | Jamaati, H. | +11

8

A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis

enthalten in: BMC infectious diseases | 2016

von Aryanpur, M. | Hosseini, M. | Masjedi, M. | +7

9

Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity

enthalten in: European journal of gastroenterology & hepatology | 2010

von Baniasadi, S. | Eftekhari, P. | Tabarsi, P. | +4

CommentIn: Eur J Gastroenterol Hepatol. 2011 Feb;23(2):193; author reply 193. - PMID 21228682

1
[1]